TPX-0005
99%
- Product Code: 102284
CAS:
1802220-02-5
| Molecular Weight: | 355.37 g./mol | Molecular Formula: | C₁₈H₁₈FN₅O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD31544350 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
TPX-0005 is primarily utilized in the field of oncology as a potent and selective inhibitor of ALK (Anaplastic Lymphoma Kinase), ROS1 (ROS Proto-Oncogene 1), and TRK (Tropomyosin Receptor Kinase) fusion proteins. Its application is critical in targeting and treating various types of cancers, particularly non-small cell lung cancer (NSCLC) and other solid tumors that harbor these genetic alterations. By inhibiting these kinases, TPX-0005 disrupts the signaling pathways that drive tumor growth and survival, offering a therapeutic option for patients with resistant or refractory cancers. It is also being investigated for its potential to overcome resistance mechanisms that develop in response to earlier-generation kinase inhibitors, making it a promising candidate for precision medicine approaches in cancer therapy.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | Ft97,160.91 |
+
-
|
TPX-0005
TPX-0005 is primarily utilized in the field of oncology as a potent and selective inhibitor of ALK (Anaplastic Lymphoma Kinase), ROS1 (ROS Proto-Oncogene 1), and TRK (Tropomyosin Receptor Kinase) fusion proteins. Its application is critical in targeting and treating various types of cancers, particularly non-small cell lung cancer (NSCLC) and other solid tumors that harbor these genetic alterations. By inhibiting these kinases, TPX-0005 disrupts the signaling pathways that drive tumor growth and survival, offering a therapeutic option for patients with resistant or refractory cancers. It is also being investigated for its potential to overcome resistance mechanisms that develop in response to earlier-generation kinase inhibitors, making it a promising candidate for precision medicine approaches in cancer therapy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :